Loading...
Muscle histopathology in children with spastic cerebral palsy receiving botulinum toxin type A
Valentine, Jane P. Stannage, Katherine Fabian, Vicki Ellis, Kevin Reid, Siobhan L. Pitcher, Christian Andrew Elliott, Catherine M.
Valentine, Jane P.
Stannage, Katherine
Fabian, Vicki
Ellis, Kevin
Reid, Siobhan L.
Pitcher, Christian Andrew
Elliott, Catherine M.
Abstract
Introduction: Botulinum toxin A ( BoNTA ) is routine treatment for hypertonicity in children with cerebral palsy ( CP ). Methods: This single-blind, prospective, cross-sectional study of 10 participants ( mean age 11 years 7 months ) was done to determine the relationship between muscle histopathology and BoNTA in treated medial gastrocnemius muscle of children with CP. Open muscle biopsies were taken from medial gastrocnemius muscle and vastus lateralis (control) during orthopedic surgery. Results: Neurogenic atrophy in the medial gastrocnemius was seen in 6 participants between 4 months and 3 years post-BoNTA. Type 1 fiber loss with type 2 fiber predominance was significantly related to the number of BoNTA injections ( r = 0.89, P < 0.001 ). Conclusions: The impact of these changes in muscle morphology on muscle function in CP is not clear. It is important to consider rotating muscle selection or injection sites within the muscle or allowing longer time between injections.
Keywords
botulinum toxin, cerebral palsy, hypertonia, medial gastrocnemius, muscle histopathology, neurogenic atrophy
Date
2016
Type
Journal article
Journal
Muscle & Nerve
Book
Volume
53
Issue
3
Page Range
407-414
Article Number
ACU Department
School of Behavioural and Health Sciences
Faculty of Health Sciences
Faculty of Health Sciences
Relation URI
Source URL
Event URL
Open Access Status
License
File Access
Controlled